title: Lung function and late pulmonary complications among survivors of hematopoietic stem cell transplantation during childhood.
abstract: Hematopoietic stem cell transplantation (HSCT) is used to treat an expanding array of malignant and non-malignant disorders. Pulmonary complications represent a significant source of morbidity and mortality in HSCT recipients. Young children, whose lungs are still developing and growing, may be especially susceptible to the insults of irradiation, drug toxicities, and recurrent infections associated with immunosuppression. Late pulmonary complications, those occurring more than three months after transplantation, are often noninfectious and present with nonspecific symptomatology. Pulmonary function testing (PFT) is a mainstay of monitoring pulmonary health in HSCT recipients. The pulmonologist should be familiar with common patterns seen on PFT in recipients of HSCT during childhood. In this review, we describe the findings in studies which have examined lung function over time in patients who underwent HSCT during childhood. We discuss patterns of PFT abnormalities, associated noninfectious syndromes and their clinical implications, as well as directions for future research.
authors.affiliation: Eudowood Division of Pediatric Respiratory Sciences, Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
authors.forename: W Adam
authors.initials: WA
authors.lastname: Gower
authors.forename: J Michael
authors.initials: JM
authors.lastname: Collaco
authors.forename: Peter J
authors.initials: PJ
authors.lastname: Mogayzel
mesh_terms: D002648:Child; D005080:Exercise Test; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects*; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects; D008171:Lung Diseases / Q000175:diagnosis / Q000209:etiology* / Q000503:physiopathology*; D012129:Respiratory Function Tests; D017741:Survivors
chemical_list: D007166:Immunosuppressive Agents